Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04505930 · ClinicalTrials.gov registry record · NA

Pilot HPV Vaccination in Chinese American Community

A NA study of Hpv, sponsored by Temple University.

Completed
Registry status
NA
Development phase
170
Enrollment target
1
Study location

NCT04505930 is a NA study of Hpv that has completed, run by Temple University. The registered enrollment target is 170 participants, below the 2,234-participant average among 24 other Hpv trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04505930, a NA study of Hpv, has completed, sponsored by Temple University.

COMPLETED
Registry status
NA
Development phase
170 participants
Enrollment target
1
Study location

Study Summary

This study provides a pioneer model in increasing knowledge of HPV vaccination among Chinese American families through culturally tailored interventions, and eventually increase the HPV vaccine uptake among Chinese American adolescents.

Conditions Studied

Interventions

  • BEHAVIORAL Interventional HPV vaccination video modules
  • BEHAVIORAL General Vaccination Education

Study Locations (1)

Pennsylvania

  • Center for Asian Health, Lewis Katz School of Medicine, Temple University - Philadelphia

Trial Details

FieldValue
Enrollment Target 170 participants
Start Date 2015-04-27
Est. Completion 2017-08-31
Phase NA

Sponsor

Temple University

163 total trials

What the Registry Record Tells You About NCT04505930

The ClinicalTrials.gov registry entry for NCT04505930 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,234-participant average among 24 other Hpv trials with a reported enrollment target (92% lower). The listed sponsor is Temple University, which has 163 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hpv appearing as the primary indexed condition, and to 2 interventions - of which Interventional HPV vaccination video modules is the first listed.

NCT04505930 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04505930 about?

NCT04505930 is a clinical study titled "Pilot HPV Vaccination in Chinese American Community". This study provides a pioneer model in increasing knowledge of HPV vaccination among Chinese American families through culturally tailored interventions, and eventually increase the HPV vaccine uptake among Chinese American adolescents.

What is the current status of trial NCT04505930?

This trial is currently completed. It is a NA study. The enrollment target is 170 participants. The study started on 2015-04-27. Estimated completion is 2017-08-31.

What conditions does trial NCT04505930 study?

This clinical trial studies the following conditions: Hpv.

What interventions are being tested in trial NCT04505930?

The interventions under investigation include: Interventional HPV vaccination video modules (BEHAVIORAL), General Vaccination Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT04505930?

This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04505930 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hpv

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.